Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Var-PVC: Varenicline for Frequent PVCs
NCT06780215Phase 2Completed
- Start
- Feb 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in premature ventricular contraction (PVC) comparing Varenicline Group with Placebo Group (2 arms). Primary endpoint: Percentage change from baseline in the 24-hour mean count of PVCs at 6 weeks. Started Feb 2025; status: completed.
02
Drugs
varenicline
03
Conditions
premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT06780215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06780215.